Selecting the Right Scale

Pearson publishes a wide range of Clinical Outcome Assessments (COAs) used globally in clinical trials. Our portfolio is available for traditional paper-and-pencil administration or can be licensed for digital use on eCOA platforms. With over 80 years of experience in test development, our assessments are built on a foundation of psychometric excellence and validated for use across diverse populations.

Our scales are applicable across various therapeutic areas to evaluate drug efficacy and track changes over time including:

  • Anxiety
  • Autism
  • Adaptive Behavior
  • ADHD
  • Behavior/Social Wellness
  • Cognitive/Neurocognitive Functioning
  • Dementia/Alzheimer’s
  • Depression
  • Executive Functioning
  • Language
  • Memory
  • Mild Cognitive Impairment
  • Motor Functioning
  • Pediatric Cognitive/Neurocognitive Functioning
  • Quality of Life
  • Schizophrenia

Considering the Bayley Scales of Infant and Toddler Development™ for your clinical trial?

The Bayley Scales of Infant and Toddler Development are among the most widely used tools in clinical trials assessing neurodevelopmental outcomes.  The release of the Bayley™-4 offers sponsors and CROs improved validity, sensitivity, and reliability in their data.

View this flyer to learn more about the key improvements in the Bayley-4 vs. the Bayley™-III.

Pharma Research Services

We are excited to partner with you in your clinical trial and have found the best way to support your unique goals and help you achieve your desired outcomes is with a conversation. Contact us to discuss your objectives to create a roadmap complete with project milestones that will set you up for success.

Contact us